Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1989-11-27
1991-02-19
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514170, 424687, A61K 3156, A61K 3310
Patent
active
049944495
ABSTRACT:
A method of increasing the bone density of post-menopausal women employs a calendar-oriented regimen of estrogen, progesterone and calcium. Such a regimen may be dispensed from a calendar-oriented pill dispenser having numerical indicia identifying each pill-containing enclosure with a given calendar date.
REFERENCES:
patent: 3409721 (1968-11-01), Applezweig
patent: 3932635 (1976-01-01), Segre
patent: 3939264 (1976-02-01), Lachnit-Fixson
patent: 3942641 (1976-03-01), Segre
patent: 3957982 (1976-05-01), Lachnit-Fixson et al.
patent: 3969502 (1976-07-01), Lachnit-Fixson
patent: 4530839 (1985-07-01), Pasquale
patent: 4534468 (1985-08-01), Nuckols et al.
patent: 4616006 (1986-10-01), Pasquale
patent: 4621079 (1986-11-01), Lachnit-Fixson et al.
patent: 4628051 (1986-12-01), Pasquale
patent: 4736849 (1988-04-01), Leonard et al.
Utian WH. Overview on Menopause, Am. J. Obstet Gynecol., 1987; 56: 1280-1283.
Ettinger, B., Overview of the Efficacy of Hormonal Replacement Therapy, AM J. Obstet. Gynecol., 1987; 56: 1298-303.
Riggs, B. L., Pathogenesis of Osteoporosis, AM. J. Obstet. Gynecol, 1987; 56: 1342-46.
Judd, H., Utian, W. H., Current Perspectives in the Management of the Menopausal and Postmenopausal Patient-Introduction: What We Hope to Learn, Am. J. Obstet. Gynecol, 1987; 56: 1279-80.
Lindsay, R., Estrogen Therapy in the Prevention and Management of Osteoporosis, Am. J. Obstet. Gynecol, 1987; 56: 1347-51.
Parfitt, Am. Quantum Concept of Bone Remodeling and Turnover: Implications for the Pathogenesis of Osteoporosis, Calif Tissue Int., 1979; 28: 1-5.
Lindsay, R., Aitken, J. M., Anderson, J. B., Hart, D. M., McDonald, E. B., Clark, A. C., Long-Term Prevention of Post-Menopausal Osteoporosis by Estrogen, Lancet 1976; 1: 1038-41.
Lindsay, R. Hart, D. M., Forrest, C., Baird, C., Prevention of Spinal Osteoporosis in Oophorectomized Women, Lancet 1980; 2: 1151-4.
Ravnikar, V. A., Compliance with Hormone Therapy, Am. J. Obstet. Gynecol, 1987; 56: 1332-34.
Genant H. K., Cann, C. E., Ettinger, B, Gordon, G. S., Quantitative Computed Tomography of Vertebral Spongiosa; a Sensitive Method for Detecting Early Bone Loss After Oophorectomy, Ann. Intern. Med., 1982; 97: 699-705.
Kolata, G., How Important is Dietary Calcium in Preventing Osteoporosis?, Science, 1986; 233: 519-20.
Barnes, D. M., Close Encounters with an Osteoclaust., Science, 1987; 236: 914-16.
Peck, W. A., Riggs, B. L., Bell, N. H., Physician's Resource Manual on Osteoporosis, Nat. Osteoporosis Found., 1987: 15-16.
Reinhold, W. D., Genant, H. K., Reiser, U. J., Harris, S. T., Ettinger, B., Bone Mineral Content in Early-Post-Menopausal and Postmenopausal Osteroporotic Women: Comparison of Measurement Methods, Radiol 1986; 160: 469-78.
Weissman, B. N., Women's Health: Osteoporosis: Radiologic and Nuclear Medicine Procedures, Nat. Con. on Women's Health, U.S. Dept. of Health and Human Services, Jul. 1986: 127-31.
Ott, S. M., Chesnut, III, C. H., Hanson, J. A., Kilcoyne, R. F., Murano, R., Lewellen, T. K., Comparison of Bone Mass Measurements Using Different Diagnostic Techniques in Patients with Postmenopausal Osteoporosis, Osteoporosis; Proc. Copenhagen Int. Sym. on Osteoporosis 1984; Jun. 3-8; 93-6.
Munk-Jensen, N., Pors Nielsen S., Obel, E. B., Bonne Eriksen, P. Reversal of Postmenopausal Vertebral Bone Loss by Oestrogen and Progestogen: a Double Blind Placebo Controlled Study, Brit. Med. Jour., Apr. 1988: 1150-1152.
Miller, P., Advances in Osteoporosis Management, Contemporary OB/GNY, Dec. 1988: 31-46.
No author, How Estrogen Protects C-V Health Unclear, OB Gyn News, Jan. 15-31, 1989; 16.
Wozney, J. M., Rosen, V., Celeste, A. J., Mitsock, L. M., Whitters, M. J., Kritz, R. W., Hewick, R. M., Wang, E. A., Novel Regulators of Bone Formation Molecular Clones and Activities, Science 242: 1528.
Ravnikar, Proper Duration of Estrogen Replacement is in Question, OB Gyn News, Jan. 15, 1989; 24: 17.
Modulus III, Inc.
Rose Shep K.
LandOfFree
Method for increasing bone density in humans does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for increasing bone density in humans, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for increasing bone density in humans will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1143741